Trailing-twelve-month (TTM) revenue is $721,387 with a year-over-year growth of (28.12%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $145,380 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-13 |
| Q4 FY2025Period ended 2025-12-31 | $263,922 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q1 FY2026Period ended 2026-03-31 | $145,954 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-14 |
| Q2 FY2026Period ended 2026-06-30 | $166,131 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $721,387 |
Current P/S: $7,002,597 market capitalization ÷ $721,387 TTM revenue = 9.71x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:02:21.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $166131.00.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:06:13.970Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|
| Grant | N/A | N/A | $204,284 |
| Product | N/A | N/A | $418,205 |
| Product Revenue | $991,473 | $770,048 | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | N/A | $52M | N/A | N/A | N/A | N/A |
| Non-US | N/A | N/A |
$721,387
$721,387
(28.12%)
vs. $1.00M a year ago (TTM)
(62.43%)
5 Year compound annual growth rate
1 Year
(28.12%)
3 Year
(53.75%)
5 Year
(62.43%)
10 Year
+51.14%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $622,489 | ($3.29M) | (84.10%) |
| 2024 | $3.92M | ($2.90M) | (42.53%) |
| 2023 | $6.81M | ($27.41M) | (80.09%) |
| 2022 | $34.22M | ($63.67M) | (65.04%) |
| 2021 | $97.89M | +$23.33M | +31.30% |
| 2020 |
TTM Growth
(28.12%)
3-Year CAGR
(53.75%)
5-Year CAGR
(62.43%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 25 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:06:13.970Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| $40,940 |
| Rest of World | $30M | $46M | $10M | $331,855 | $391,836 | N/A |
|---|
| United States | $45M | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | N/A | N/A | $25M | $659,618 | $378,212 | $581,549 |
|---|
| $74.55M |
| +$74.34M |
| +34579.90% |
| 2019 | $214,974 | +$175,063 | +438.63% |
| 2018 | $39,911 | +$32,249 | +420.90% |
| 2017 | $7,662 | ($2,338) | (23.38%) |
